Pd-L1
Device pharmDx
General payments
$14,078
Research payments
$690,423
Through program year 2020, $14,078 in general payments and $690,423 in research payments were reported against Pd-L1 (pharmDx).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $10,733 | 10 |
| 2020 | Research | $200,000 | 1 |
| 2019 | General | $3,345 | 4 |
| 2019 | Research | $490,423 | 5 |
Breakdown
Each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2020 where a state was reported.
Records
14 general · 6 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.